| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |